RayzeBio Inc. Common Stoc... (RYZB)

NASDAQ: RYZB · Real-Time Price · USD

62.49

0.01 (0.02%)

At close: Feb 23, 2024, 9:00 PM

RayzeBio Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-68.6M	-29.44M	-6.92M
Depreciation & Amortization	1.53M	455K	213K
Stock-Based Compensation	6.33M	1.99M	29K
Other Working Capital	2.52M	1.29M	n/a
Other Non-Cash Items	6.9M	-6.85M	4.05M
Deferred Income Tax	-351K	1.43M	1K
Change in Working Capital	2.52M	1.29M	289K
Operating Cash Flow	-51.68M	-31.13M	-2.33M
Capital Expenditures	-9.1M	-5.6M	-461K
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	-146.97M	-190.51M	-3.14M
Sales Maturities Of Investments	128.85M	43.39M	n/a
Other Investing Acitivies	n/a	-18.69M	n/a
Investing Cash Flow	-27.21M	-171.4M	-3.6M
Debt Repayment	n/a	n/a	n/a
Common Stock Repurchased	-1.91M	-22K	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	157.54M	109.52M	149.8M
Financial Cash Flow	157.54M	109.52M	149.8M
Net Cash Flow	78.65M	-93.01M	143.86M
Free Cash Flow	-60.78M	-36.72M	-2.79M